Fractyl Health, Inc. (GUTS) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon, and welcome to Fractal Health's first quarter 2025 financial results and business updates call. As a reminder, this conference call is being recorded. At this time, all participants are in listen-only mode. There will be a question and answer session following management prepared remarks. I'll now turn the call over to Brian Luque, head of investment relations and corporate development at Fractal. Brian, you may now begin. Thank you. This afternoon, we issued a press release that outlines the topics we plan to discuss today. This release is available at www.fractal.com under the Investors tab. Joining us on the call today are Dr. Harith Rajagopalan, Chief Executive Officer, and Lisa Davidson, Chief Financial Officer. During this call, we make forward-looking statements which involve risks and uncertainties that may cause actual results to differ materially from our forward-looking statements. We provide a comprehensive list of risk factors in our SEC filings, including the quarterly report on Form 10-Q filed today, which I encourage you to review. Any forward-looking statements on the call are subject to substantial risks and uncertainties, speak only as of the call's original date, and we undertake no obligation to update or revise any of the statements, even if subsequent events cause the company's views to change. It is now my pleasure to pass the call over to Harish. Thank you, Brian. Good afternoon, everyone. Thank you for joining us today. With multiple data readouts from Reveal 1 and Remain 1, key commercial insights in weight maintenance, and a regulatory filing in Rejuva 001 expected over the course of the next two quarters, 2025 is poised to be a year of acceleration for Fractal. When we went public in early 2024, we did so with a bold ambit...